BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Waly Raphael S, Yangde Z, Yuxiang C. Hepatocellular carcinoma: focus on different aspects of management. ISRN Oncol 2012;2012:421673. [PMID: 22655206 DOI: 10.5402/2012/421673] [Cited by in Crossref: 25] [Cited by in F6Publishing: 45] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Panera N, Crudele A, Romito I, Gnani D, Alisi A. Focal Adhesion Kinase: Insight into Molecular Roles and Functions in Hepatocellular Carcinoma. Int J Mol Sci 2017;18:E99. [PMID: 28067792 DOI: 10.3390/ijms18010099] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]
2 Ma DN, Chai ZT, Zhu XD, Zhang N, Zhan DH, Ye BG, Wang CH, Qin CD, Zhao YM, Zhu WP, Cao MQ, Gao DM, Sun HC, Tang ZY. MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2. J Hematol Oncol 2016;9:1. [PMID: 26733151 DOI: 10.1186/s13045-015-0229-y] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 9.5] [Reference Citation Analysis]
3 Xiao J, Liu R, Chen CS. Tree shrew (Tupaia belangeri) as a novel laboratory disease animal model. Zool Res 2017;38:127-37. [PMID: 28585436 DOI: 10.24272/j.issn.2095-8137.2017.033] [Cited by in Crossref: 17] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
4 Hu Q, Lou GG, Liu YC, Qian L, Lv BD. The Tumor Necrosis Factor-α-308 and -238 Polymorphisms and Risk of Hepatocellular Carcinoma for Asian Populations: A Meta-Analysis. Curr Ther Res Clin Exp 2014;76:70-5. [PMID: 25352937 DOI: 10.1016/j.curtheres.2014.04.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
5 Khawar IA, Park JK, Jung ES, Lee MA, Chang S, Kuh HJ. Three Dimensional Mixed-Cell Spheroids Mimic Stroma-Mediated Chemoresistance and Invasive Migration in hepatocellular carcinoma. Neoplasia. 2018;20:800-812. [PMID: 29981501 DOI: 10.1016/j.neo.2018.05.008] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 11.0] [Reference Citation Analysis]
6 Shetty S, U A, Kumar R, Bharati S. Electrical conductivity spectra of hepatic tumors reflect hepatocellular carcinoma progression in mice. Biomed Phys Eng Express 2020;6. [PMID: 35062002 DOI: 10.1088/2057-1976/abbbd5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Lin CC, Wu CH, Chen LY, Tsai MC, Elsarawy AM, Huang KT. Coagulation factor VII gene polymorphisms are not associated with the occurrence or the survival of hepatocellular carcinoma: a report of 37 cases. Cancer Biol Med 2018;15:275-81. [PMID: 30197794 DOI: 10.20892/j.issn.2095-3941.2017.0144] [Reference Citation Analysis]
8 Wang QL, Liu BO, Li XJ, Hu KP, Zhao K, Ye XM. Inhibition of mTOR promotes hyperthermia sensitivity in SMMC-7721 human hepatocellular carcinoma cell line. Exp Ther Med 2016;11:961-8. [PMID: 26998020 DOI: 10.3892/etm.2016.2979] [Reference Citation Analysis]
9 Li T, Liu Y, Sun Y. Long non-coding RNA AB209630 suppresses cell proliferation and metastasis in human hepatocellular carcinoma. Exp Ther Med 2017;14:3419-24. [PMID: 29042928 DOI: 10.3892/etm.2017.4927] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
10 Kou X, Zhu J, Xie X, Hao M, Zhao Y. Expression of lncRNA MSC-AS1 in hepatocellular carcinoma cell lines and its effect on proliferation, apoptosis, and migration. Turk J Gastroenterol 2020;31:860-7. [PMID: 33625998 DOI: 10.5152/tjg.2020.19485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Lu X, Sun W, Tang Y, Zhu L, Li Y, Ou C, Yang C, Su J, Luo C, Hu Y. Identification of key genes in hepatocellular carcinoma and validation of the candidate gene, cdc25a, using gene set enrichment analysis, metaanalysis and crossspecies comparison. Mol Med Rep. 2016;13:1172-1178. [PMID: 26647881 DOI: 10.3892/mmr.2015.4646] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
12 Huang Y, Liu J, Fan L, Wang F, Yu H, Wei W, Sun G. miR-663 overexpression induced by endoplasmic reticulum stress modulates hepatocellular carcinoma cell apoptosis via transforming growth factor beta 1. Onco Targets Ther 2016;9:1623-33. [PMID: 27073326 DOI: 10.2147/OTT.S96902] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
13 Zhang G, Zhang G. Upregulation of FoxP4 in HCC promotes migration and invasion through regulation of EMT. Oncol Lett 2019;17:3944-51. [PMID: 30930991 DOI: 10.3892/ol.2019.10049] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
14 Vara D, Morell C, Rodríguez-Henche N, Diaz-Laviada I. Involvement of PPARγ in the antitumoral action of cannabinoids on hepatocellular carcinoma. Cell Death Dis 2013;4:e618. [PMID: 23640460 DOI: 10.1038/cddis.2013.141] [Cited by in Crossref: 66] [Cited by in F6Publishing: 63] [Article Influence: 7.3] [Reference Citation Analysis]
15 Janevska D, Chaloska-Ivanova V, Janevski V. Hepatocellular Carcinoma: Risk Factors, Diagnosis and Treatment. Open Access Maced J Med Sci. 2015;3:732-736. [PMID: 27275318 DOI: 10.3889/oamjms.2015.111] [Cited by in Crossref: 58] [Cited by in F6Publishing: 57] [Article Influence: 8.3] [Reference Citation Analysis]
16 Ng J, Wu J. Hepatitis B- and hepatitis C-related hepatocellular carcinomas in the United States: similarities and differences. Hepat Mon 2012;12:e7635. [PMID: 23233865 DOI: 10.5812/hepatmon.7635] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
17 Anwar DM, Khattab SN, Helmy MW, Kamal MK, Bekhit AA, Elkhodairy KA, Elzoghby AO. Lactobionic/Folate Dual-Targeted Amphiphilic Maltodextrin-Based Micelles for Targeted Codelivery of Sulfasalazine and Resveratrol to Hepatocellular Carcinoma. Bioconjug Chem 2018;29:3026-41. [PMID: 30110148 DOI: 10.1021/acs.bioconjchem.8b00428] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
18 Ferrasi AC, Fernandez GJ, Grotto RMT, Silva GF, Goncalves J, Costa MC, Enguita FJ, Pardini MIMC. New LncRNAs in Chronic Hepatitis C progression: from fibrosis to hepatocellular carcinoma. Sci Rep 2020;10:9886. [PMID: 32555359 DOI: 10.1038/s41598-020-66881-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Tkachev AV, Tarasova GN, Groshilin VS, Vasilchenkov DA, Ushakova TI, Blinov DV. [Prevalence of nonalcoholic fatty liver disease in outpatients in Rostov-on-Don: Regional results of the DIREG-2 study]. Ter Arkh 2016;88:59-66. [PMID: 27636929 DOI: 10.17116/terarkh201688859-66] [Reference Citation Analysis]
20 Vakhrushev YM, Suchkova EV, Lukashevich AP. [Non - alcoholic fatty liver disease and enteral insufficiency: comorbidity of their development]. Ter Arkh 2019;91:84-9. [PMID: 32598594 DOI: 10.26442/00403660.2019.12.000134] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Ibrahim TR, Abdel-Raouf SM. Immunohistochemical Study of Glypican-3 and HepPar-1 in Differentiating Hepatocellular Carcinoma from Metastatic Carcinomas in FNA of the Liver. Pathol Oncol Res 2015;21:379-87. [PMID: 25108409 DOI: 10.1007/s12253-014-9830-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
22 Kim EH, Kim MS, Furusawa Y, Uzawa A, Han S, Jung WG, Sai S. Metformin enhances the radiosensitivity of human liver cancer cells to γ-rays and carbon ion beams. Oncotarget 2016;7:80568-78. [PMID: 27802188 DOI: 10.18632/oncotarget.12966] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
23 Alqahtani A, Khan Z, Alloghbi A, Said Ahmed TS, Ashraf M, Hammouda DM. Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies. Medicina (Kaunas) 2019;55:E526. [PMID: 31450841 DOI: 10.3390/medicina55090526] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 10.0] [Reference Citation Analysis]
24 Radwan NA, Ahmed NS. The diagnostic value of arginase-1 immunostaining in differentiating hepatocellular carcinoma from metastatic carcinoma and cholangiocarcinoma as compared to HepPar-1. Diagn Pathol. 2012;7:149. [PMID: 23111165 DOI: 10.1186/1746-1596-7-149] [Cited by in Crossref: 59] [Cited by in F6Publishing: 45] [Article Influence: 5.9] [Reference Citation Analysis]
25 Zeng T, Tang Z, Liang L, Suo D, Li L, Li J, Yuan Y, Guan XY, Li Y. PDSS2-Del2, a new variant of PDSS2, promotes tumor cell metastasis and angiogenesis in hepatocellular carcinoma via activating NF-κB. Mol Oncol 2020;14:3184-97. [PMID: 33064899 DOI: 10.1002/1878-0261.12826] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Xu GS, Li ZW, Huang ZP, Brunicardi FC, Jia F, Song C, Zou HJ, Sun RF. MiR-497-5p inhibits cell proliferation and metastasis in hepatocellular carcinoma by targeting insulin-like growth factor 1. Mol Genet Genomic Med 2019;7:e00860. [PMID: 31441605 DOI: 10.1002/mgg3.860] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
27 Xing T, Huang L, Yu Z, Zhong L, Wang S, Peng Z. Comparison of steroid-free immunosuppression and standard immunosuppression for liver transplant patients with hepatocellular carcinoma. PLoS One 2013;8:e71251. [PMID: 23940730 DOI: 10.1371/journal.pone.0071251] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
28 Kim H, Yu SJ, Yeo I, Cho YY, Lee DH, Cho Y, Cho EJ, Lee JH, Kim YJ, Lee S, Jun J, Park T, Yoon JH, Kim Y. Prediction of Response to Sorafenib in Hepatocellular Carcinoma: A Putative Marker Panel by Multiple Reaction Monitoring-Mass Spectrometry (MRM-MS). Mol Cell Proteomics 2017;16:1312-23. [PMID: 28550167 DOI: 10.1074/mcp.M116.066704] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
29 Zhang LY, Liu M, Li X, Tang H. miR-490-3p modulates cell growth and epithelial to mesenchymal transition of hepatocellular carcinoma cells by targeting endoplasmic reticulum-Golgi intermediate compartment protein 3 (ERGIC3). J Biol Chem. 2013;288:4035-4047. [PMID: 23212913 DOI: 10.1074/jbc.m112.410506] [Cited by in Crossref: 102] [Cited by in F6Publishing: 74] [Article Influence: 10.2] [Reference Citation Analysis]
30 He G, Fu S, Li Y, Li T, Mei P, Feng L, Cai L, Cheng Y, Zhou C, Tang Y, Huang W, Liu H, Cen B, Pan M, Gao Y. TCGA and ESTIMATE data mining to identify potential prognostic biomarkers in HCC patients. Aging (Albany NY) 2020;12:21544-58. [PMID: 33177245 DOI: 10.18632/aging.103943] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Zhang W, Liu K, Liu S, Ji B, Wang Y, Liu Y. MicroRNA-133a functions as a tumor suppressor by targeting IGF-1R in hepatocellular carcinoma. Tumor Biol 2015;36:9779-88. [DOI: 10.1007/s13277-015-3749-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 43] [Article Influence: 5.4] [Reference Citation Analysis]
32 Li Y, Wang X, Li Z, Liu B, Wu C. MicroRNA-4651 represses hepatocellular carcinoma cell growth and facilitates apoptosis via targeting FOXP4. Biosci Rep 2020;40:BSR20194011. [PMID: 32436934 DOI: 10.1042/BSR20194011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Yada M, Masumoto A, Motomura K, Tajiri H, Morita Y, Suzuki H, Senju T, Koyanagi T. Indicators of sorafenib efficacy in patients with advanced hepatocellular carcinoma. World J Gastroenterol 2014; 20(35): 12581-12587 [PMID: 25253961 DOI: 10.3748/wjg.v20.i35.12581] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
34 Zeng G, Gill US, Kennedy PTF. Prioritisation and the initiation of HCC surveillance in CHB patients: lessons to learn from the COVID-19 crisis. Gut 2020;69:1907-12. [PMID: 32451325 DOI: 10.1136/gutjnl-2020-321627] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
35 Chen X, Han Y, Zhan S, Wang C, Chen S. Tegillarca granosa Extract Haishengsu Induces Apoptosis in Human Hepatocellular Carcinoma Cell Line BEL-7402 Via Fas-Signaling Pathways. Cell Biochem Biophys 2015;71:837-44. [DOI: 10.1007/s12013-014-0271-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
36 Wu L, Zhao X, Ma H, Zhang L, Li X. Discoidin Domain Receptor 1, a Potential Biomarker and Therapeutic Target in Hepatocellular Carcinoma. IJGM 2022;Volume 15:2037-44. [DOI: 10.2147/ijgm.s348110] [Reference Citation Analysis]
37 Saleh A, Saed AM, Mansour M. Association of IL-10 and TNF-α polymorphisms with risk and aggressiveness of hepatocellular carcinoma in patients with HCV-related cirrhosis. Egypt Liver Journal 2020;10. [DOI: 10.1186/s43066-020-00052-w] [Reference Citation Analysis]
38 Wickline ED, Du Y, Stolz DB, Kahn M, Monga SP. γ-Catenin at adherens junctions: mechanism and biologic implications in hepatocellular cancer after β-catenin knockdown. Neoplasia 2013;15:421-34. [PMID: 23555187 DOI: 10.1593/neo.122098] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.7] [Reference Citation Analysis]
39 Yi L, He S, Cheng Z, Chen X, Ren X, Bai Y, Santhekadur PK. DNAJA1 Stabilizes EF1A1 to Promote Cell Proliferation and Metastasis of Liver Cancer Mediated by miR-205-5p. Journal of Oncology 2022;2022:1-15. [DOI: 10.1155/2022/2292481] [Reference Citation Analysis]
40 Moawad AW, Szklaruk J, Lall C, Blair KJ, Kaseb AO, Kamath A, Rohren SA, Elsayes KM. Angiogenesis in Hepatocellular Carcinoma; Pathophysiology, Targeted Therapy, and Role of Imaging. J Hepatocell Carcinoma 2020;7:77-89. [PMID: 32426302 DOI: 10.2147/JHC.S224471] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
41 Sun M, Zhao X, Liang L, Pan X, Lv H, Zhao Y. Sialyltransferase ST3GAL6 mediates the effect of microRNA-26a on cell growth, migration, and invasion in hepatocellular carcinoma through the protein kinase B/mammalian target of rapamycin pathway. Cancer Sci 2017;108:267-76. [PMID: 27906498 DOI: 10.1111/cas.13128] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
42 Li CW, Chang PY, Chen BS. Investigating the mechanism of hepatocellular carcinoma progression by constructing genetic and epigenetic networks using NGS data identification and big database mining method. Oncotarget 2016;7:79453-73. [PMID: 27821810 DOI: 10.18632/oncotarget.13100] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
43 Liu Y, Bi T, Dai W, Wang G, Qian L, Gao Q, Shen G. Oxymatrine synergistically enhances the inhibitory effect of 5-fluorouracil on hepatocellular carcinoma in vitro and in vivo. Tumour Biol 2016;37:7589-97. [PMID: 26687645 DOI: 10.1007/s13277-015-4642-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
44 Lee JH, Poudel B, Ki HH, Nepali S, Lee YM, Shin JS, Kim DK. Complement C1q stimulates the progression of hepatocellular tumor through the activation of discoidin domain receptor 1. Sci Rep 2018;8:4908. [PMID: 29559654 DOI: 10.1038/s41598-018-23240-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
45 Yeermaike A, Gu P, Liu D, Nadire T. LncRNA NEAT1 sponges miR-214 to promoted tumor growth in hepatocellular carcinoma. Mamm Genome 2022. [PMID: 35357550 DOI: 10.1007/s00335-022-09952-1] [Reference Citation Analysis]
46 Ye Z, Chen X, Chen X. ARK5 promotes invasion and migration in hepatocellular carcinoma cells by regulating epithelial-mesenchymal transition. Oncol Lett 2018;15:1511-6. [PMID: 29434843 DOI: 10.3892/ol.2017.7453] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
47 Bo QF, Sun XM, Liu J, Sui XM, Li GX. Antitumor action of the peroxisome proliferator-activated receptor-γ agonist rosiglitazone in hepatocellular carcinoma. Oncol Lett 2015;10:1979-84. [PMID: 26622783 DOI: 10.3892/ol.2015.3554] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
48 Zhou H, Xu J, Zhang C, Wen Y. Aberrant histone deacetylase 1 expression upregulates vimentin expression via an NF-κB-dependent pathway in hepatocellular carcinoma. Oncol Lett 2019;18:339-47. [PMID: 31289505 DOI: 10.3892/ol.2019.10309] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Niu ZS, Niu XJ, Wang WH. Genetic alterations in hepatocellular carcinoma: An update. World J Gastroenterol 2016; 22(41): 9069-9095 [PMID: 27895396 DOI: 10.3748/wjg.v22.i41.9069] [Cited by in CrossRef: 78] [Cited by in F6Publishing: 79] [Article Influence: 13.0] [Reference Citation Analysis]
50 Bao YX, Cao Q, Yang Y, Mao R, Xiao L, Zhang H, Zhao HR, Wen H. Expression and prognostic significance of golgiglycoprotein73 (GP73) with epithelial-mesenchymal transition (EMT) related molecules in hepatocellular carcinoma (HCC). Diagn Pathol. 2013;8:197. [PMID: 24313979 DOI: 10.1186/1746-1596-8-197] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
51 Chen CZ, Rao SX, Ding Y, Zhang SJ, Li F, Gao Q, Zeng MS. Hepatocellular carcinoma 20 mm or smaller in cirrhosis patients: early magnetic resonance enhancement by gadoxetic acid compared with gadopentetate dimeglumine. Hepatol Int 2014;8:104-11. [PMID: 26202411 DOI: 10.1007/s12072-013-9467-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
52 Shu G, Mi X, Cai J, Zhang X, Yin W, Yang X, Li Y, Chen L, Deng X. Brucine, an alkaloid from seeds of Strychnos nux-vomica Linn., represses hepatocellular carcinoma cell migration and metastasis: the role of hypoxia inducible factor 1 pathway. Toxicol Lett 2013;222:91-101. [PMID: 23933019 DOI: 10.1016/j.toxlet.2013.07.024] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]